title: TRP64ARG beta 3-adrenergic receptor and obesity in Mexican Americans.
abstract: The beta 3-adrenergic receptor (beta 3AR) is expressed in visceral fat and is a regulator of resting metabolic rate, thermogenesis, and lipolysis. We genotyped 61 unrelated Mexican Americans for a variant in the beta 3AR gene (codon 64 TGGTrp-->CGGArg; TRP64ARG). The allele frequency was 0.13. The TRP64ARG variant was significantly associated with an earlier age of onset of non-insulin-dependent diabetes mellitus (41.3 +/- 4.6 years vs 55.6 +/- 2.6 years; P < 0.02) and in non-diabetics, with elevated 2-h insulin levels during an oral glucose tolerance test (810 +/- 120 pmol/l vs 384 +/- 6 pmol/l; P < 0.005). Non-diabetic subjects with the variant allele tended to have higher body mass indices (BMI), waist-to-hip ratios, and diastolic blood pressures. The study group was expanded to include 421 related subjects from 31 families in the San Antonio Family Diabetes Study. Using a measured genotype analysis approach to estimate genotype-specific means for each trait, those who were homozygous for the TRP64ARG variant had significantly higher 2-h insulin levels (P = 0.036) and trends towards higher BMI compared to the other two genotypes. We detected no associations of these traits in the TRP64ARG heterozygotes in the larger group. We conclude that the TRP64ARG beta 3AR variant is a susceptibility gene for several features of the insulin resistance syndrome in Mexican Americans. Since its effects are modest, study design (e.g., subject selection, genetic background, and statistical analyses) may influence which traits are associated with this variant and whether or not the effect is detectable in heterozygotes.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Md., USA. KSILVER@UMPPA1.AB.UMD.EDU
authors.forename: K
authors.initials: K
authors.lastname: Silver
authors.forename: B D
authors.initials: BD
authors.lastname: Mitchell
authors.forename: J
authors.initials: J
authors.lastname: Walston
authors.forename: J D
authors.initials: JD
authors.lastname: Sorkin
authors.forename: M P
authors.initials: MP
authors.lastname: Stern
authors.forename: J
authors.initials: J
authors.lastname: Roth
authors.forename: A R
authors.initials: AR
authors.lastname: Shuldiner
mesh_terms: D001120:Arginine / Q000235:genetics; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000209:etiology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics; D008297:Male; D017058:Mexican Americans / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D009765:Obesity / Q000150:complications / Q000209:etiology / Q000235:genetics*; D011943:Receptors, Adrenergic, beta / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3; D013577:Syndrome; D013781:Texas; D014364:Tryptophan / Q000235:genetics
chemical_list: D007328:Insulin; D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3; D014364:Tryptophan; D001120:Arginine